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CASE REPORT
PARACOCCIDIOIDOMYCOSIS IN A RENAL TRANSPLANT RECIPIENT 
Heliana Freitas de Oliveira GÓES(1), Sandra Maria Barbosa DURÃES(1), Caren dos Santos LIMA(1), Mariana Boechat de SOUZA(1),  
Enoi Aparecida Guedes VILAR(2) & Marcos Olivier DALSTON(3)
SUMMARY
Paracoccidioidomycosis (PCM) is the most common endemic mycosis in Latin America. The etiological agents, which comprise 
two species, Paracoccidioides brasiliensis and P. lutzii, are thermodimorphic fungi that usually affect previously healthy adults. 
They primarily involve the lungs and then disseminate to other organs. Such mycosis is rare in organ transplant recipients; there 
have been only three cases reported in literature, until now. We report a case of PCM in a renal transplant recipient with an unusual 
dermatological presentation.
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INTRODUCTION
Fungal infections comprise only 5% of all infections in renal 
transplant recipients. Both epidemiological exposure and the state of 
immunosuppression determine the type of systemic fungal infection. 
Candida and Aspergillus species are the most frequently reported fungal 
pathogens causing infection following renal transplantation1,2. 
Paracoccidioidomycosis (PCM) is an endemic infection in Latin 
America; the etiological agents3, which include two species, P. 
brasiliensis and P. lutzii, are thermodimorphic fungi that usually affect 
previously healthy adults. They primarily involve the lungs and then 
disseminate to other organs. However, such mycosis is rare in organ 
transplant recipients. There have only been three cases reported in 
literature, until now, that presented such mycosis complicating the 
transplantation of solid organs, all of which being renal transplant 
recipients2,4,5.
We present one more case of PCM in an organ transplant recipient, 
with unusual dermatological presentation.
CASE REPORT
A white, sixty-six-year-old man born and residing in Miracema, Rio 
de Janeiro, was admitted in August 2014 for having had cough for three 
months, weight loss of six kg in a month, and febrile episodes over the 
10 previous days. The patient underwent renal transplantation in January 
2013 and he was using prednisone, 5 mg/day; mesalazine, 1,080 mg/
day; and tacrolimus, 8 mg/day. He had systemic arterial hypertension, 
diabetes mellitus and gout, controlled with oral medications. He used 
to visit a farm and perform soil management frequently. Physical 
examination showed good general conditions, there was no palpable 
lymphadenopathy; dermatological examination revealed shallow 
ulcerated lesions on the palate surrounded by erythema, measuring about 
8 mm; multiple mulberry-like erythematous eroded papules giving to the 
lesion a cobblestone appearance (Aguiar-Pupo stomatitis); erythematous 
papule with a central umbilication of about 3 mm located at the left nasal 
wing (Fig. 1); and an infiltrated erythematous plaque with irregular 
borders and indistinct boundaries, of approximately 1 cm in diameter, 
located on the left flank (Fig. 2).
Chest x-rays showed bilateral nodular infiltrate, so it was started 
empirical treatment for tuberculosis and bacterial pneumonia. AFB 
bronchial lavage was negative however, the direct mycological examination 
found fungal structures compatible with paracoccidioidomycosis. 
Biopsies in the described mucocutaneous lesions were performed, 
including oral ulcers, which were consistent with this diagnosis 
(Fig. 3). All materials were subjected to culture and there was growth 
of P. brasiliensis. Itraconazole, 400 mg daily, was started, but after five 
days of treatment the patient had clinical worsening and liposomal 
amphotericin B was introduced. The basal serum cortisol was normal 
and abdominal CT scan showed no specific changes; however, in lung 
CT (Fig. 4) an extensive involvement with bilateral nodular infiltrates, 
an excavated area suggestive of necrosis in the middle third of the right 
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lung, and bilateral pleural effusion, largest in the right lung, were seen. 
Despite the prescribed therapies, the patient died.
DISCUSSION
PCM is the most common endemic mycosis in Latin America. Brazil 
is the country with the largest number of cases of the disease, with an 
estimated incidence ranging between 10-30 cases/million of inhabitants, 
and a mortality rate of 1.4 deaths/million of inhabitants. PCM diagnosis 
is based on clinical symptoms, direct microscopic examination of clinical 
specimens, isolation of fungus in culture, and detection of specific 
antibodies by serological techniques4,6.
The systemic mycoses most observed in the immediate post-
transplant period are coccidioidomycosis and histoplasmosis while 
PCM and blastomycosis are rare2. PCM in solid organ transplant 
patients was firstly reported in 19847, with similar presentation in 
an immunocompetent patient; then in 19955, with severe pulmonary 
infection that progressed to death; and in 20042, with similar presentation 
in an immunocompetent patient with unusual radiological findings. 
This case is the fourth to be reported in literature. In previous reports, 
patients followed immunosuppressive regimens with combinations of 
azathioprine, cyclosporine and prednisone. The clinical manifestations 
of PCM were atypical, with unusual pulmonary manifestations8. The 
mean time for onset of fungal infections following transplantation was 
11 years; in the present case it was one year and seven months, beyond 
having presented unusual skin lesions, not described in any of the 
previous PCM cases.
Several radiological findings are found in PCM, but none are 
pathognomonic. The most common is a mixed alveolar and interstitial 
infiltrate diffusely distributed in both lungs. Cavitations are infrequent 
and when present are small, single or multiple, located around central 
areas of the lungs2,9. Therefore, the present report is even rarer for its 
unusual radiological presentation.
Fig. 4 - Bilateral nodular infiltrates, excavated area with suggestive area of necrosis in the 
middle third of the right lung and bilateral pleural effusion
Fig. 3 - A and B - Chronic granulomatous process with pseudoepitheliomatous hyperplasia 
and ulceration with numerous fungal cells (H&E X40); C - numerous oval / round cells with 
multiple budding, like a “pilot wheel” cell (Groccot X40)
Fig. 2 - Infiltrated erythematous plaque on the left flank
Fig. 1 - Erythematous papule with a central umbilication in the left nasal wing, shallow 
ulcerated lesions on the palate and Aguiar Pupo stomatitis
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Regarding treatment, amphotericin B deoxycholate (classical 
amphotericin B) in doses of 0.75 to 1.0 mg/kg/day, at a total dose 
equivalent of 30 mg/kg of body weight, and itraconazole at doses of 
200 to 400 mg/day for six to 12 months, are the therapeutic options10. 
Maintenance treatment is indicated and can be performed weekly or 
biweekly with amphotericin B or itraconazole 200 mg/day. We must 
always consider the possibility of drug interactions between these drugs 
and those routinely used by transplant patients8. 
This case demonstrates the importance of early diagnosis and 
intervention in diseases that affect immunosuppressed patients; although 
PCM is an endemic mycosis in Brazil, it is not reported frequently in 
this group of patients. In addition, if there is appearance of skin lesions, 
they should always be addressed for early diagnosis.
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